Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conditioning regimens for allogeneic stem cell transplants.

A J Barrett1

  • 1Allogeneic Stem Cell Transplant Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institute of Health, Bethesda, Maryland 20892, USA. barrettj@nih.gov

Current Opinion in Hematology
|October 31, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Elastase-Like Enzyme of Platelets.

Thrombosis and haemostasis·2019
Same author

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.

Bone marrow transplantation·2017
Same author

High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.

Bone marrow transplantation·2017
Same author

Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.

Bone marrow transplantation·2016
Same author

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system.

Bone marrow transplantation·2016
Same author

Rapid Remission Induction and Improved Disease Free Survival in Acute Myeloid Leukaemia Using Daunorubicin, ARA-C, and CCNU.

Leukemia & lymphoma·2016
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Novel nonmyeloablative transplant conditioning regimens offer a safer approach to allogeneic transplantation. These reduced-intensity treatments enhance graft-versus-malignancy effects, improving outcomes for various cancers.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Allogeneic transplantation conditioning regimens aim for cytoreduction and immunosuppression to enable donor engraftment and graft-versus-malignancy (GVM) effects.
  • Traditional myeloablative regimens carry significant toxicity, limiting their application, especially in older patients.

Purpose of the Study:

  • To explore the conceptual shift towards reduced-intensity conditioning regimens in allogeneic transplantation.
  • To evaluate the efficacy and safety of novel nonmyeloablative conditioning treatments.

Main Methods:

  • Development and application of novel nonmyeloablative conditioning regimens for allogeneic transplantation.
  • Assessment of regimen-related toxicity and transplant-related mortality.
  • Evaluation of graft-versus-malignancy effects in myeloid, lymphoid malignancies, and metastatic renal cell cancer.

Related Experiment Videos

Main Results:

  • Novel nonmyeloablative conditioning regimens demonstrate low regimen-related toxicity and low transplant-related mortality.
  • These transplants effectively confer a graft-versus-malignancy effect across diverse malignancies.

Conclusions:

  • Nonmyeloablative conditioning represents a paradigm shift, enhancing transplant safety and applicability.
  • Future directions include combining low-toxicity conditioning with targeted antibody therapies and utilizing mismatched transplants.